CHEMICAL GENOMICS 2006
Small Molecules to Discover Targets

Part of Fourth Annual Discovery on Target 2006

October 24-25, 2006 World Trade Center Boston, MA

The targets of many drug candidates are unknown and are often difficult to tease out from among the thousands of gene products found in a typical organism. The blindness in the welter of potential cellular targets means that the process of designing therapeutic drugs is neither precise nor efficient. The exploration of chemical genomics will transform our understanding of how the human genome and proteome function. This conference will examine how to best identify new targets for therapy and the tools used to drive drug programs.


Preliminary Topic List

*

Advances in High-Throughput Screening
*

Elucidate the Link Between Targets and Underlying Physiology
*

Biochemical-Based Target Screening
*

Rational Design of Multiple Action Compounds
*

Qualitative and Quantitative Measures of Small Molecule Chemical Diversity
*

Functional Diversity of Small Molecules: Max-Min Concept
*

Novel Chemical Scaffolds
*

Synthesis of Pharmacophores of Natural Products
*

Molecular Complexity: Combinatorial Chemistry
*

Validate New Targets for Novel Therapies
*

Target Protein Assisting Small Molecule Selection
*

Reverse Chemical Genomics

If you would like to give an oral presentation at this symposium, please submit a proposal including a title and brief summary of your recent work.

All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference.

To submit a proposal for consideration please click here

For more information, please contact:
Holly Groelle, Ph.D., Conference Director, Cambridge Healthtech Institute
Phone: 617-630-1355 E-mail: hgroelle@healthtech.com

For exhibits and sponsorship information, please contact:
David Karp at 617-630-1383 or dkarp@healthtech.com